Streetbeat News

Regulatory

TPCS

TechPrecision Corporation has received a notice from Nasdaq for non-compliance due to a delayed filing of its quarterly report. The company has until September 16, 2024, to submit a compliance plan, with a possible extension to January 13, 2025. There is no immediate impact on its Nasdaq listing or trading.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 8:08 pm

MNPR

Monopar Therapeutics has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 8:06 pm

NVDA

Cryptocurrency markets, including Bitcoin, Ethereum, and Dogecoin, are experiencing a downturn as traders anticipate economic data releases and Nvidia's earnings. Despite the decline, Bitcoin's transaction volume and active addresses have surged, with many traders going long. The SEC is set to challenge Kraken, and Nasdaq seeks approval for Bitcoin index options.

Portfolio Pulse from Khyathi Dalal

August 27, 2024 | 8:06 pm

KARS

TSLA

Tesla shares are trading lower due to Canada's 100% tariff on Chinese EV imports, affecting Tesla's exports from its Shanghai factory. The EV sector faces trade tensions, stalling demand, and increased competition. Tesla's Cybertruck also faces negative publicity.

Portfolio Pulse from Vaishali Prayag

August 27, 2024 | 7:36 pm

ABBV

BMY

LLY

NBIX

The FDA is expected to approve a new schizophrenia drug from Karuna Therapeutics, recently acquired by Bristol Myers Squibb, on September 26. This innovative treatment aims to reduce severe side effects common in existing medications. The development marks a significant advancement in schizophrenia treatment, a field that hasn't seen new types of drugs in over 70 years.

Portfolio Pulse from Anthony Noto

August 27, 2024 | 7:22 pm

AVCNF

Avicanna Inc. has secured a US patent for its topical cannabinoid technology aimed at treating pain and inflammation. This technology, part of Avicanna's RHO Phyto portfolio, offers an alternative to traditional pain relief methods by delivering active ingredients directly into deep tissue layers, potentially providing better efficacy with fewer side effects.

Portfolio Pulse from Juan Spínelli

August 27, 2024 | 6:54 pm

ALK

BA

HA

SPR

An Alaska Airlines flight using a Boeing 737-700 experienced engine trouble, forcing it to return to Seattle. Boeing is under scrutiny for safety issues and is seeking to acquire Spirit AeroSystems. Alaska Airlines is attempting a merger with Hawaiian Holdings.

Portfolio Pulse from Michael Juliano

August 27, 2024 | 6:46 pm

CGC

Canopy Growth Corp's stock fell 10% after the DEA delayed its decision on cannabis rescheduling, creating uncertainty in the cannabis market. This delay affects Canopy's U.S. expansion plans and investor sentiment, amid political uncertainties regarding cannabis legalization.

Portfolio Pulse from Henry Khederian

August 27, 2024 | 6:39 pm

VCNX

Vaccinex has been granted a U.S. patent for the use of semaphorin-4D antibodies in combination with immune modulating therapy to inhibit tumor growth and metastasis. This patent could enhance Vaccinex's position in cancer treatment innovation.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:34 pm

BIOX

The USDA has confirmed that genetically modified wheat developed by Bioceres can be safely grown and bred in the United States. This approval marks a significant step for Bioceres in expanding its agricultural biotechnology products in the US market.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:27 pm